Catalog No.
Product Name
Application
Product Information
Citations
-
Aceclofenac Impurity
Aceclofenac methyl ester is a key impurity of Aceclofenac, an orally active nonsteroidal anti-inflammatory drug (NSAID) recognized for its analgesic and anti-inflammatory effects. This compound is significant for research applications involving the characterization and validation of Aceclofenac, allowing for a comprehensive analysis of its pharmacological profile and potential impact in various inflammatory conditions. -
Drug Intermediate
2-(3-Pyridyl)-4-methyl-thiazole-5-carboxylic acid is a synthetic intermediate utilized in pharmaceutical synthesis. This compound serves as a building block for the development of various drug candidates, contributing to the formation of thiazole-based pharmacophores. It is applicable in medicinal chemistry for creating novel therapeutics with potential biological activity. -
Drug Impurity
Clopidogrel impurity 10 is an impurity associated with the antiplatelet drug Clopidogrel, which primarily targets the P2Y12 receptor on platelets. This impurity is critical for evaluating the purity and quality of Clopidogrel formulations in pharmaceutical research. It serves as a reference standard in drug development and quality control processes, ensuring the reliability of therapeutic applications. -
Drug Impurity
Beclometasone dipropionate impurity 9 is a known impurity associated with the corticosteroid Beclometasone dipropionate. It serves as a critical reference standard for quality control and analysis in pharmaceutical development, ensuring the purity and safety of corticosteroid formulations. Its characterization is essential for regulatory compliance and in assessing the stability and efficacy of related drug products. -
Drug Intermediate Control
2-Methyl-4-phenyl thiazole is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a crucial building block in the production of various bioactive molecules, facilitating the development of potential therapeutics. Its application spans across medicinal chemistry, where it aids in the design and optimization of new drug candidates. -
Drug Impurity
Atorvastatin impurity 9 is a chemical impurity associated with the statin drug Atorvastatin. It is primarily studied for its role in drug quality control and formulation integrity. This impurity is relevant for researchers investigating the safety and efficacy profiles of Atorvastatin, contributing to the understanding of its pharmacological properties and potential impacts on patient treatment outcomes. -
Drug Impurity
Chlorthalidone impurity 2 is an identified impurity associated with the antihypertensive agent Chlorthalidone. This compound is primarily utilized in analytical chemistry to assess the purity and quality of Chlorthalidone in pharmaceutical formulations. It serves as a crucial reference standard for researchers investigating the metabolite profile and potential side effects of Chlorthalidone-based therapies. -
Drug Intermediate
(1S,3S)-3-Aminomethyl-cyclopentanol is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its structural framework provides a valuable scaffold for the development of various bioactive compounds, making it essential in medicinal chemistry. This reagent is applicable in research focused on the synthesis of novel therapeutics and drug discovery. -
Drug Impurity
Tamsulosin impurity 3 is a recognized impurity associated with Tamsulosin, a selective alpha-1 adrenergic antagonist. This compound serves as an important reference standard in the pharmaceutical industry for quality control and stability testing of Tamsulosin formulations. Its characterization aids in ensuring the purity and safety of therapeutic preparations utilizing Tamsulosin. -
Drug Impurity
Fenirofibrate impurity 2 is a minor impurity associated with the lipid-modulating drug Fenirofibrate. This compound is relevant for drug quality control and stability testing in pharmaceutical research. Its identification and quantification play a crucial role in ensuring the purity and safety of Fenirofibrate formulations, aiding in the development of effective therapeutic strategies for dyslipidemia. -
Drug Impurity
Trazodone impurity 1, also known as Trazodone 1,4-Di-N-oxide, is a known impurity associated with the pharmaceutical compound Trazodone. This reagent is utilized primarily in the assessment of drug purity and stability during analytical testing. Its presence and quantification are critical for ensuring the quality of Trazodone formulations in pharmaceutical research and development. -
Drug Impurity
Lidocaine impurity 20 is a known impurity associated with the local anesthetic agent Lidocaine. This compound serves as a critical reference standard for quality control during the synthesis and analysis of Lidocaine formulations. Its identification and characterization are essential for ensuring the purity and efficacy of Lidocaine-containing products in pharmaceutical research and development. -
Drug Impurity
Trazodone impurity 2, also known as Dechloro trazodone, is a known impurity associated with the pharmaceutical compound Trazodone. This compound may be utilized in the assessment of drug purity and stability during formulation development and quality control processes. Its analysis can provide valuable insights into the chemical profile of Trazodone formulations, aiding in the understanding of potential impacts on efficacy and safety. -
Drug Impurity
Ethinylestradiol impurity 2, also known as 16-Oxo ethynyl estradiol, serves as a notable impurity in the synthesis of Ethinylestradiol. Its characterization is essential for quality control and regulatory compliance in pharmaceutical development. This compound can be utilized in various analytical applications, including stability studies and impurity profiling, providing critical insights into the purity and safety of hormone-related therapeutic formulations. -
Drug Impurity
Clobazam impurity 4 is a chemical impurity associated with the pharmaceutical agent Clobazam, a benzodiazepine used primarily for its anxiolytic properties. This impurity may arise during the synthesis of Clobazam and is relevant for analytical chemistry and quality control in drug development. Research applications include the assessment of drug purity, stability studies, and pharmacokinetic investigations. -
Drug Impurity
Trazodone impurity 4 hydrochloride is a chemical impurity associated with Trazodone hydrochloride. It serves as an important reference standard in the evaluation of drug purity and is relevant for quality control processes in pharmaceutical research. The presence of this impurity can impact the pharmacological profile and safety of formulations containing Trazodone, making it essential for analytical methods in drug development and regulatory compliance. -
Drug Impurity
Candesartan impurity 11 is a chemical impurity associated with Candesartan, an angiotensin II receptor antagonist. This impurity is significant for quality control and analytical studies in pharmaceutical research, particularly for characterizing Candesartan formulations. Its presence can affect the safety and efficacy profiles of drug products, making it essential for thorough impurity profiling in drug development processes. -
Drug Impurity
Sitagliptin impurity 19 is a chemical impurity associated with the antidiabetic agent Sitagliptin. It is utilized primarily in pharmaceutical development and quality control to assess the purity and stability of Sitagliptin formulations. This reagent is essential for ensuring compliance with regulatory standards and for conducting detailed investigations into the drug's chemical profile. -
Drug Impurity
Rivaroxaban impurity 33 is a drug impurity associated with Rivaroxaban, an anticoagulant that inhibits Factor Xa. This impurity is vital for quality control and analytical studies in pharmaceutical development and can be used in characterizing the purity of Rivaroxaban formulations. Its presence is significant for researchers involved in drug safety assessments and regulatory compliance in pharmaceutical research. -
Drug Impurity
Betamethasone dipropionate impurity 2 is a known impurity of the corticosteroid, Betamethasone dipropionate, which serves as a glucocorticoid receptor agonist. This compound may be relevant for research involving the purification and characterization of drug formulations, as well as studies on the stability and efficacy of corticosteroid therapies. Understanding this impurity is essential for ensuring quality control in the production of pharmacologically active compounds. -
Drug Impurity
Dabigatran impurity 2 is a quality control reference standard identified as an impurity of Dabigatran. This compound is utilized primarily in analytical chemistry for the detection and quantification of impurities in Dabigatran formulations. It serves as a critical reagent for research focused on the pharmacokinetics and safety profiles of anticoagulant medications. -
Drug Impurity
Donepezil impurity 21 is a known impurity of the cognitive-enhancing agent Donepezil, which primarily targets acetylcholinesterase to enhance cholinergic neurotransmission. This compound is essential for the analysis of Donepezil formulations, particularly in the context of pharmaceutical quality control and regulatory compliance. Its characterization aids in understanding the stability and purity of Donepezil, supporting ongoing research in neurodegenerative disease therapies. -
Drug Impurity
Lincomycin impurity 4 is a known impurity associated with lincomycin, an antibiotic that targets the bacterial ribosome to inhibit protein synthesis. This compound serves as an important reference standard for quality control and analytical assessment in pharmaceutical development and research. It is valuable for studying the stability, efficacy, and safety profiles of lincomycin formulations. -
Drug Impurity
Oxcarbazepine impurity 3, also known as 11-Keto Oxcarbazepine, is a recognized impurity of the anticonvulsant drug Oxcarbazepine. This compound is relevant in the pharmaceutical research and quality control of antiepileptic medications. Its presence and characterization are essential for ensuring the purity and efficacy of drug formulations. -
Drug Impurity
Hydrocortisone impurity 3 (Cortexolone hemisuccinate) is a known impurity of hydrocortisone, primarily utilized in quality control and analytical research. It serves as an important reference standard for assessing the purity of hydrocortisone formulations. Research applications include stability testing and identification of degradation products in pharmaceutical development. -
Drug Impurity
Haloperidol impurity 10 is a characterized impurity of the antipsychotic drug Haloperidol. It serves as a reference standard in quality control and analytical studies, aiding in the assessment of drug purity. This compound is essential for researchers focused on drug development and regulatory compliance, allowing for the evaluation of related substances and potential effects on therapeutic efficacy. -
Drug Impurity
Cinacalcet impurity 9 is a known impurity of the calcium-sensing receptor modulator, Cinacalcet. This compound serves as a reference standard for quality control and method validation in pharmaceutical research. Its characterization is essential for ensuring the purity and efficacy of Cinacalcet-containing formulations, aiding in the development of robust analytical methods in drug formulation studies. -
Drug Impurity
Amlodipine impurity 6 is a specific impurity associated with Amlodipine, a calcium channel blocker. This compound is primarily utilized in analytical and quality control applications to ensure the purity of Amlodipine formulations. Its characterization is crucial for regulatory compliance and the development of safe and effective therapeutic agents. -
Drug Impurity
Ketoconazole impurity 6 is a known impurity associated with Ketoconazole, a commonly used antifungal agent. The identification and characterization of this impurity are crucial for ensuring the quality and safety of pharmaceutical formulations. This compound can serve as a reference standard in drug development and analytical studies, aiding in the assessment of Ketoconazole purity and stability in various research applications. -
Drug Impurity
Cetirizine impurity 2 is a chemical impurity associated with the antihistamine cetirizine. It is primarily utilized in pharmaceutical research to assess the quality and purity of cetirizine formulations. This compound plays a crucial role in stability testing and compliance with regulatory standards for drug substances. -
Drug Intermediate
BOC-(1R,3S)-3-aminocyclopentane carboxylic acid is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its structural components make it valuable in the development of bioactive compounds, particularly in generating cyclic amino acids. This compound supports various research applications, including the synthesis of peptidomimetics and the exploration of drug candidates targeting specific biological pathways. -
Drug Impurity
Dacomitinib impurity 1 is a known impurity of the targeted therapy Dacomitinib, which acts as an irreversible inhibitor of the epidermal growth factor receptor (EGFR). This compound is primarily utilized in quality control and stability testing within pharmaceutical research to ensure the purity and efficacy of Dacomitinib formulations. Its presence is crucial for understanding potential impacts on drug performance and safety in therapeutic applications. -
Drug Impurity
Testosterone impurity 11 is a known impurity associated with the synthesis of testosterone. Its presence in formulations may affect the purity and efficacy of therapeutic preparations. This compound is relevant in analytical chemistry, particularly in the assessment of drug quality and safety for research applications focusing on steroid hormones and their derivatives. -
Drug Impurity
Albendazole impurity 2 is a known impurity of the anthelmintic agent albendazole, primarily investigated for its potential impact on drug quality and safety. This compound is essential for the assessment of purity in pharmaceutical formulations of albendazole and can be used in the development and validation of analytical methods. It plays a crucial role in ensuring compliance with regulatory standards and quality control in drug manufacturing processes. -
Drug Impurity
Rivaroxaban impurity 20 is a known impurity of the anticoagulant Rivaroxaban, functioning primarily as a pharmacological marker in chemical analysis. This reagent is essential for the development and quality control of pharmaceutical formulations, enabling researchers to assess the purity and safety of Rivaroxaban products. Its characterization is crucial in compliance with regulatory standards during synthesis and formulation processes. -
Drug Impurity
Simvastatin impurity 5, also known as (3S,5S)-Dihydroxy simvastatin, is a drug impurity associated with Simvastatin. It serves as a valuable reference standard for quality control and analytical testing in pharmaceutical research. The careful characterization of this impurity aids in ensuring the purity and efficacy of Simvastatin formulations, contributing to compliance with regulatory standards in drug development. -
Drug Impurity
Rosuvastatin impurity 45 is a synthesized impurity associated with Rosuvastatin, a potent HMG-CoA reductase inhibitor. This compound serves as an important reference standard for quality control and analytical testing in pharmaceutical research. Its characterization is essential for evaluating the purity and ensuring the efficacy of Rosuvastatin formulations in clinical applications. -
Drug Impurity
Ethinylestradiol impurity 5, also known as 6β-Hydroxy Ethynyl Estradiol, is a recognized impurity associated with the synthesis of Ethinylestradiol. This compound has significant relevance in pharmaceutical analysis, particularly for assessing the purity and efficacy of estrogen-based therapies. Its characterization is essential for regulatory compliance and quality control in the production of hormonal medications. -
Drug Impurity
Rivastigmine impurity 7 is a recognized impurity derived from Rivastigmine, a reversible inhibitor of the enzyme acetylcholinesterase. This compound is primarily utilized in pharmaceutical research to study the purity and stability of Rivastigmine formulations. Its presence is critical in ensuring the quality and efficacy of cholinesterase inhibitors for therapeutic applications, particularly in the treatment of Alzheimer's disease. -
Drug Impurity
Esazomide impurity 11 is a chemical impurity associated with the drug Esazomide. This compound may serve as a valuable reference standard for quality control and analytical studies. Its presence in formulations can be critical for assessing the purity and safety profiles of Esazomide in pharmaceutical development and research applications. -
Drug Impurity
Sitagliptin impurity 13 is a known impurity associated with the DPP-4 inhibitor Sitagliptin. It is relevant for quality control and characterization studies in pharmaceutical research. This impurity can be used in the analysis of Sitagliptin formulations to ensure compliance with regulatory standards and to assess the purity of the active pharmaceutical ingredient. -
Drug Impurity
Alfacalcidol impurity 1 is a characterized impurity of Alfacalcidol, a vitamin D analog that acts primarily through the vitamin D receptor (VDR). This compound is critical for ensuring the purity and quality control of Alfacalcidol in pharmaceutical formulations. It is valuable for research applications involving drug metabolism, pharmacokinetics, and stability testing of vitamin D derivatives. -
Drug Impurity
Rosuvastatin impurity 24 is a characterized impurity of the cholesterol-lowering agent Rosuvastatin. Its presence is critical for the quality control and analytical assessment of Rosuvastatin formulations. This impurity serves as an important reference standard for pharmacological studies and can aid in the investigation of the drug's stability and safety profiles. -
Drug Impurity
Itraconazole impurity 6 is identified as an impurity associated with Itraconazole, a triazole antifungal agent. It is primarily utilized in pharmaceutical research to evaluate the purity and quality of Itraconazole formulations. This compound serves as a critical reference standard for analytical methods, aiding in the assessment of drug stability and efficacy in various biological assays. -
Drug Impurity
Cetirizine impurity 13 is a significant impurity associated with the antihistamine Cetirizine, primarily arising during its synthesis. This compound is essential for studies focused on drug quality and stability, particularly in the context of pharmaceutical development and regulatory compliance. It serves as a critical reference standard for the analysis of drug substances and formulations, contributing to the understanding of impurity profiles and their potential effects on therapeutic efficacy and safety. -
Drug Impurity
Dexamethasone impurity 5 is a chemical impurity associated with the corticosteroid Dexamethasone. It is primarily utilized in pharmaceutical research to assess the purity of Dexamethasone formulations and to ensure compliance with regulatory standards. This compound plays a crucial role in the characterization of drug substances and can be important in quality control processes within the pharmaceutical industry. -
Drug Impurity
Ketoprofen impurity 8 is a structural variant of the nonsteroidal anti-inflammatory drug (NSAID) ketoprofen. It serves as a significant marker for quality control and analytical assessment in pharmaceutical research. This impurity can be utilized in the study of drug stability, efficacy, and the potential impact of impurities on pharmacological activity. Its presence and concentration can inform the optimization of synthesis and formulation processes in drug development. -
Drug Intermediate Control
(1S,3R)-3-Aminocyclopentanol functions as a versatile synthetic intermediate in pharmaceutical development. This compound is integral for the synthesis of various biologically active molecules, contributing to the advancement of medicinal chemistry. Its chiral nature allows for the production of enantioselective compounds, making it valuable in the design of targeted therapeutics. -
Drug Impurity
Tepyrimidine impurity 9 is a known impurity associated with Tepyrimidine. This compound can serve as a reference material for quality control and analytical purposes in pharmaceutical research. Its presence and characterization are crucial for ensuring the purity of Tepyrimidine in drug formulation and synthesis, supporting compliance with safety and efficacy standards in drug development. -
Drug Impurity
Rufinamide impurity 1, also known as 2,6-Didesfluoro rufinamide, is a known impurity associated with the pharmaceutical compound Rufinamide. This chemical is primarily used for analytical purposes, including quality control and validation in the synthesis of Rufinamide. Researchers can utilize Rufinamide impurity 1 to study its effects on drug formulation and ensure the purity of pharmaceutical products.
